NewsBot
09-May-23, 17:00
The Caithness Business Index (http://www.caithness-business.co.uk) has posted the following article:
Moderna COVID-19 vaccine Spikevax authorised for use in infants and children aged 6 months to 5 years
The COVID-19 vaccine from Moderna has met the MHRA's required safety, quality and effectiveness standards to be authorised for use in this age group. Spikevax, the COVID-19 vaccine from Moderna, has today been authorised for use in children aged 6 months to 5 years. [Read Full Article (https://caithness-business.co.uk/article/20119)]
Moderna COVID-19 vaccine Spikevax authorised for use in infants and children aged 6 months to 5 years
The COVID-19 vaccine from Moderna has met the MHRA's required safety, quality and effectiveness standards to be authorised for use in this age group. Spikevax, the COVID-19 vaccine from Moderna, has today been authorised for use in children aged 6 months to 5 years. [Read Full Article (https://caithness-business.co.uk/article/20119)]